Omega-3 and omega-6 polyunsaturated fatty acid levels and correlations with symptoms in children with attention deficit hyperactivity disorder, autistic spectrum disorder and typically developing controls

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Parletta, Natalie ^a   Niyonsenga, Theophile ^a   Duff, Jacques ^b,c  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b Behavioural Neurotherapy Clinic   (Australia)

^c Australian Autism ADHD Foundation   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; AUSTRALIAN TWIN BEHAVIOUR RATING SCALE; AUTISM; BEHAVIOR ASSESSMENT; BLOOD SAMPLING; CHILD; CHILDHOOD AUTISM RATING SCALE; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; RATING SCALE; TEST OF VARIABLE ATTENTION; BLOOD; CASE CONTROL STUDY; PRESCHOOL CHILD;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; MALE;

EID: 84971620549     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156432     Document Type: Article

References (70)

1. Pliszka SR. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: An overview. J Clin Psychiatry. 1998; 59(suppl 7):50-8. PMID: 9680053
2. Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatry disorders in children with austism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry. 2008; 47(8):921-9. doi: 10.1097/CHI.0b013e318179964f PMID: 18645422
3. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry. 2007; 164(6):942-8. PMID: 17541055
4. Zablotsky B, Black LI, Maenner MJ, Scheive LA, Blumberg SJ. National Health Statistics Reports. US Department of Health and Human Services, 2013.
5. Muhle R, Trentacoste SV, Rapin IR. The genetics of autism. Pediatrics. 2004; 113(5):e472-e86. PMID: 15121991
6. Nikolas M, Burt AS. Genetic and environmental influences on ADHD symptom dimensions of inattention and hyperactivity: A meta-analysis. J Abnorm Psychol. 2010; 119(1):1-17. doi: 10.1037/a0018010 PMID: 20141238
7. Grandjean P, Landrigan PJ. Neurobehavioural effects of developmental toxicity. The Lancet Neurol. 2014; 13(3):330-8. doi: 10.1016/S1474-4422(13)70278-3 PMID: 24556010
8. Miller CS. The compelling anomaly of chemical intolerance. Ann N Y Acad Sci. 2001; 933(1):1-23.
9. Howard AL, Robinson M, Smith GJ, Ambrosini GL, Piek JP, Oddy WH. ADHD is associated with a "Western" dietary pattern in adolescents. J Atten Disord. 2011; 15(5):403-11. doi: 10.1177/1087054710365990 PMID: 20631199
10. Kohlboeck G, Sausenthaler S, Standl M, Koletzko S, Bauer C-P, von Berg A, et al. Food intake, diet quality and behavioral problems in children: results from the GINI-plus/LISA-plus studies. Ann Nutr Metab. 2012; 60:247-56. doi: 10.1159/000337552 PMID: 22677949
11. Wiles NJ, Northstone K, Emmett P, Lewis G. 'Junk food' diet and childhood behavioural problems: results from the ALSPAC cohort. Eur J Clin Nutr. 2007; 63:491-8. PMID: 18059416
12. Rowland AS, Lesesne CA, Abramowitz AJ. The epidemiology of attention-deficit/hyperactivity disorder (ADHD): A public health view. Ment Retard Dev Disabil Res Rev. 2002; 8(3):162-70. PMID: 12216060
13. Pärtty A, Kalliomaki M, Wacklin P, Salminen S, Isolauri E. A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatr Res. 2015; 77(6):823-8. doi: 10.1038/pr.2015.51 PMID: 25760553
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Arlington, Va: American Psychiatric Association; 2013.
15. Charach A, Ickowicz A, Schachar R. Stimulant treatment over five years: adherence, effectiveness, and adverse effects. Journal of the American Academy of Child & Adolescent Psychiatry. 2004; 43 (5):559-67.
16. Jensen PS, Arnold EL, Swanson JM, Vitiello B, Abikoff HB, Greenhill LL, et al. 3-year follow-up of the NIMH MTA Study. J Am Acad Child Adolesc Psychiatry. 2007; 46(8):989-1002. PMID: 17667478
17. Molina BSG, Flory K, Hinshaw SP, Greiner AR, Arnold LE, Swanson JM, et al. Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry. 2007; 46(8):1028-40. PMID: 17667481
18. MTA Cooperative Group. National Institute of Mental Health multimodal treatment study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics. 2004; 113:762-9. PMID: 15060225
19. Swanson JM, Elliott GR, Greenhill LL, Wigal T, Eugene AL, Vitiello B, et al. Effects of Stimulant Medication on Growth Rates Across 3 Years in the MTA Follow-up. J Am Acad Child Adolesc Psychiatry. 2007; 46(8):1015-27. PMID: 17667480
20. Curtis LT, Patel K. Nutritional and environmental approaches to preventing and treating autism and attention deficit hyperactivity disorder (ADHD): A review. J Altern Complement Med. 2008; 14(1):79-85. doi: 10.1089/acm.2007.0610 PMID: 18199019
21. Transler C, Eilander A, Mitchell S, van de Meer N. The impact of polyunsaturated fatty acids in reducing child attention deficit and hyperactivity disorders. J Atten Disord. 2010; 14(3):232-46. doi: 10.1177/1087054709347250 PMID: 20424008
22. Sinn N. Nutritional and dietary influences on attention deficit hyperactivity disorder. Nutr Rev. 2008; 66 (10):558-68. doi: 10.1111/j.1753-4887.2008.00107.x PMID: 18826452
23. Sinn N, Wilson C. Dietary supplementation with highly unsaturated fatty acids: Implications for interventions with persons with mental retardation from research on infant cognitive development, ADHD, and other developmental disabilities. Int Rev Res Ment Retard. 2006; 32:159-96.
24. Gow RV, Hibbeln JR, Parletta N. Current evidence and future directions for research with omega-3 fatty acids and attention deficit hyperactivity disorder. Curr Opin Clin Nutr Metab Care. 2015; 18(2):133-8. doi: 10.1097/MCO.0000000000000140 PMID: 25581035
25. Parletta N, Milte CM, Meyer B. Nutritional modulation of cognitive function and mental health. J Nutr Biochem. 2013; 24(5):725-43. doi: 10.1016/j.jnutbio.2013.01.002 PMID: 23517914
26. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med. 2008; 233(6):674-88.
27. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002; 56(8):365-79. PMID: 12442909
28. Sinn N, Howe PRC. Mental health benefits of omega-3 fatty acids may be mediated by improvements in cerebral vascular function. Biosci Hypotheses. 2008; 1(2):103-8.
29. Hawkey E, Nigg JT. Omega-3 fatty acid and ADHD: Blood level analysis and meta-analytic extension of supplementation trials. Clin Psychol Rev. 2014; 34(6):496-505. doi: 10.1016/j.cpr.2014.05.005 PMID: 25181335
30. Antalis CJ, Stevens LJ, Campbell M, Pazdro R, Ericson K, Burgess JR. Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids. 2006; 75:299-308. PMID: 16962757
31. Chen J-R, Hsu S-F, Hsu C-D, Hwang L-H, Yang S-C. Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan. J Nutr Biochem. 2004; 15:467-72. PMID: 15302081
32. Laasonen M, Hokkanen L, Leppämäki S, Tani P, Erkkilä AT. Project DyAdd: Fatty acids and cognition in adults with dyslexia, ADHD, or both. Prostaglandins Leukot Essent Fatty Acids. 2009; 81:79-88. doi: 10.1016/j.plefa.2009.04.004 PMID: 19464861
33. Milte CM, Parletta N, Buckley J, Coates A, Young R, Howe P. Increased erythrocyte eicosapentaenoic acid and docosahexaenoic acid are associated with improved attention and behaviour in children with ADHD in a 12-month randomised controlled three-way crossover trial. J Atten Disord. 2015; 19(11):954-964. doi: 10.1177/1087054713510562 PMID: 24214970
34. Vancassel S, Durand G, Barthelemy C. Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids. 2001; 65:1-7. PMID: 11487301
35. Wiest MM, German JB, Harvey DJ, Watkins SM, Hertz-Picciotto I. Plasma fatty acid profiles in autism: A case-control study. Prostaglandins Leukot Essent Fatty Acids. 2009; 80(4):221-7. doi: 10.1016/j.plefa.2009.01.007 PMID: 19307110
36. Bell JG, MacKinlay EE, Dick JR, MacDonald DJ, Boyle RM, Glen ACA. Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins Leukot Essent Fatty Acids. 2004; 71:201-4. PMID: 15301788
37. Bell JG, Sargent JR, Tocher DR, Dick JR. Red blood cell fatty acid compositions in a patient with autistic spectrum disorder: a characteristic abnormality in neurodevelopmental disorders? Prostaglandins Leukot Essent Fatty Acids. 2000; 63(2/1):21-5.
38. Bu B, Ashwood P, Harvey D, King IB, Van de Water J, Jin L-W. Fatty acid compositions of red blood cell phospholipids in children with autism. Prostaglandins Leukot Essent Fatty Acids. 2006; 74(4):215-21. PMID: 16581239
39. Greenberg LM, Waldman ID. Developmental normative data on the Test of Variables of Attention (TOVA). J Child Adolesc Psychiatry. 1993; 34:1019-30.
40. Llorente AM, Voigt R, Jensen CL, Fraley JK, Heird WC, Rennie KM. The Test of Variables of Attention (TOVA): Internal consistency (Q1 vs. Q2 and Q3 vs. Q4) in children with Attention Deficit/Hyperactivity Disorder (ADHD). Child Neuropsychol. 2008; 14(4):314-22. doi: 10.1080/09297040701563578 PMID: 17917866
41. Levy F, Hay D, McStephen M, Wood C, Waldman I. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry. 1997; 36(6):737-44. PMID: 9183127
42. Schopler E, Reichler RJ, DeVellis RF, Daly K. Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). J Autism Dev Disord. 1980; 10(1):91-103. PMID: 6927682
43. Shamberger RJ. Erythrocyte fatty acid studies in patients. J Adv Med. 1997; 10(3):195-205.
44. Milte C, Sinn N, Howe PRC. Polyunsaturated fatty acid status in ADHD, depression and dementia: towards an omega-3 index for mental health? Nutr Rev. 2009; 67(10):573-90. doi: 10.1111/j.1753-4887.2009.00229.x PMID: 19785689
45. Colter AL, Cutler C, Meckling KA. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case control study. Nutr J. 2008; 7:8. doi: 10.1186/1475-2891-7-8 PMID: 18275609
46. Joshi K, Lad S, Kale M, Patwardhan B, Mahadik SP, Patni B, et al. Supplementation with flax oil and vitamin C improves the outcome of attention deficity hyperactivity disorder (ADHD). Prostaglandins Leukot Essent Fatty Acids. 2006; 74:17-21. PMID: 16314082
47. Young G, Maharaj NJ, Conquer J. Blood phospholipid fatty acid analysis of adults with and without attention deficit/hyperactivity disorder. Lipids. 2004; 39:117-23. PMID: 15134138
48. Montgomery P, Burton JR, Sewell RP, Spreckelsen TF, Richardson AJ. Low blood long chain omega-3 fatty acids in UK children are associated with poor cognitive performance and behavior: A cross-sectional analysis from the DOLAB study. PLoS ONE. 2013; 8(6):e66697. doi: 10.1371/journal.pone.0066697 PMID: 23826114
49. Brigandi SA, Shao H, Qian SY, Shen Y, Wu B-L, Kang JX. Autistic children exhibit decreased levels of essential fatty acids in red blood cells. Int J Mol Sci. 2015; 16(5):10061-76. doi: 10.3390/ijms160510061 PMID: 25946342
50. Harris WS, von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med. 2004; 39:212-20. PMID: 15208005
51. Reiersen AM, Todd RD. Co-occurrence of ADHD and autism spectrum disorders: phenomenology and treatment. Expert Review Neurother. 2008; 8(4):657-69.
52. Richardson AJ. Long-chain polyunsaturated fatty acids in childhood develpomental and psychiatric disorders. Lipids. 2004; 39(12):1215-22. PMID: 15736918
53. Bos DJ, Oranje B, Veerhoek ES, Van Diepen RM, Weusten JM, Demmelmair H, et al. Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder. Neuropsychopharmacol. 2015.
54. McNamara RK, Able J, Jandacek R, Rider T, Tso P, Eliassen JC, et al. Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebocontrolled, dose-ranging, functional magnetic resonance imaging study. Am J Clin Nutr. 2010; 91:1060-7. doi: 10.3945/ajcn.2009.28549 PMID: 20130094
55. Vaisman N, Kaysar N, Zaruk-Adasha Y, Pelled D, Brichon G, Zwingelstein G, et al. Corelation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids. Am J Clin Nutr. 2008; 87:1170-80. PMID: 18469236
56. Sinn N, Bryan J, Wilson C. Cognitive effects of polyunsaturated fatty acids in children with attention deficit hyperactivity disorder symptoms: A randomised controlled trial. Prostaglandins LeukotEssent Fatty Acids. 2008; 78(4-5):311-26.
57. Richardson AJ, Burton JR, Sewell RP, Montgomery P. Docosahexaenoic acid for reading, cognition and behaviour in children aged 7-9 years: A randomised, controlled trial (the DOLAB study). PLoS ONE. 2012; 7(9):E43909. doi: 10.1371/journal.pone.0043909 PMID: 22970149
58. Richardson AJ, Montgomery P. The Oxford-Durham study: a randomised, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics. 2005; 115:1360-6. PMID: 15867048
59. Johnson M, Östlund S, Fransson G, Kadesjö B, Gillberg C. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder. J Atten Disord. 2009; 12(5):394-401. doi: 10.1177/1087054708316261 PMID: 18448859
60. Sinn N, Bryan J. Effect of supplementation with polyunsaturated fatty acids and micronutrients on ADHD-related problems with attention and behavior. J Dev Behav Pediatr. 2007; 28(2):82-91. PMID: 17435458
61. Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: Systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2011; 50(10):991-1000. doi: 10.1016/j.jaac.2011.06.008 PMID: 21961774
62. Sinn N, Milte C, Howe PRC. Oiling the brain: A review of randomised controlled trials of omega-3 fatty acids in psychopathology across the lifespan. Nutrients. 2010; 2(2):128-70. doi: 10.3390/nu2020128 PMID: 22254013
63. Milte C, Sinn N, Buckley JD, Coates AM, Young RM, Howe PRC. Erythrocyte polyunsaturated fatty acids, cognition and literacy in children with ADHD with and without learning difficulties. J Child Health Care. 2011; 15(4):299-311. doi: 10.1177/1367493511403953 PMID: 21828168
64. Milte CM, Parletta N, Buckley JD, Coates AM, Young RM, Howe PRC. Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention deficit hyperactivity disorder: A randomized controlled trial. Nutrition. 2012; 28(6):670-7. doi: 10.1016/j.nut.2011.12.009 PMID: 22541055
65. Ng K-H, Meyer B, Reece L, Sinn N. Dietary polyunsaturated fatty acid intakes in children with ADHD symptoms. Br J Nutr. 2009; 102:1635-41. doi: 10.1017/S0007114509990821 PMID: 19631022
66. Johnson CR, Handen BL, Mayer-Costa M, Sacco K. Eating habits and dietary status in young children with autism. J Dev Phys Disabil. 2008; 20(5):437-48.
67. Ming X, Stein TP, Brimacombe M, Johnson WG, Lambert GH, Wagner GC. Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot Essent Fatty Acids. 2005; 73:379-84. PMID: 16081262
68. Richardson AJ, Ross MA. Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot Essent Fatty Acids. 2000; 63(1/2):1-9.
69. Wall R, Marques TM, O'Sullivan O, Ross RP, Shanahan F, Quigley EM, et al. Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota. Am J Clin Nutr. 2012; 95:1278-87. doi: 10.3945/ajcn.111.026435 PMID: 22492373
70. Willemsen LE, Koetsier MA, Balvers M, Beermann C, Stahl B, van Tol EAF. Polyunsaturated fatty acids support epithelial barrier integrity and reduce IL-4 mediated permeability in vitro. Eur J Nutr. 2008; 47 (4):183-91. doi: 10.1007/s00394-008-0712-0 PMID: 18497998